Fundz

Coeptis Therapeutics Holdings

Pennsylvania, United States · Blockchain, Cryptocurrency, Healthcare · 5 employees

Funding history

  • Series series b — $22.0M — Apr 2026

Recent signals

  • Apr 29, 2026: Raised $22.0M in Series series b
  • Apr 28, 2026: Z Squared Appoints Michelle Burke as Co-Chief Executive Officer and Ryan Schadel as Chief Marketing Officer
  • Apr 24, 2026: Acquired Z Squared completes merger with Coeptis Therapeutics
  • Apr 24, 2026: Acquired Coeptis completes merger with Z Squared
  • Apr 08, 2026: Acquired Coeptis Therapeutics Announces Merger with Z Squared Inc.
  • Apr 07, 2026: Acquired Coeptis to acquire Z Squared, transforming structure
  • Apr 07, 2026: SEC 8-K (8.01): On April 7, 2026, Coeptis Therapeutics Holdings, Inc. announced via a press release that Nasdaq has approved the listing of the post-merger company's common stock on the Nasdaq Global Market under the ticker symbol 'ZSQR'. This approval is contingent upon customary conditions and the closing of the proposed merger with Z Squared Inc. The strategic implications of this merger and listing are significant as it indicates a successful transition to a new entity that may enhance trading volume and attract more investors.
  • Jan 07, 2025: Coeptis Therapeutics Secures Five New Clients for NexGenAI Marketing Platform

See plans & pricing → Track Coeptis Therapeutics Holdings’s funding, hiring, and signals — with verified contacts — on Fundz.